Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease

Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00493493

Enrollment

Registered

2007-06-28

Start date

2007-01-31

Completion date

2008-06-30

Last updated

2007-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Sinus

Keywords

Cymetra

Brief summary

Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective study that will evaluate the results of surgical pore excision, curettage, and injection of a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.

Detailed description

In addition, the study will evaluate the credibility and reproducibility of results within other surgeons trained to perform the procedure. Data collection will focus on post-operative wound failure, infection ratwes, analgesic requirements, time lost from work or school, wound care requirements, and 6 month recurrence rates. These outcomes will be compared to outcomes using conventional pilonidal surgical intervention using published data.

Interventions

PROCEDUREsurgery (Pore Excision, Curettage, and Injection of Cymetra)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Any patient with pilonidal diseas

Design outcomes

Primary

Measure	Time frame
wound failure, time lost from work or school, analgesic requirements, recurrence rates	6 months

Secondary

Measure	Time frame
infection rates, wound care requirements	6 months

Countries

United States

Contacts

Primary ContactJames J Matino, MD

jimanderin@yahoo.com860-249-8595

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026